INTRAVENOUS IMMUNE GLOBULIN FORMULATION CONTAINING A NON-IONIC SURFACE ACTIVE AGENT WITH IMPROVED PHARMACOKINETIC PROPERTIES - Patent 0973549

(19)

(11)

EP 0 973 549 A2

(12)

(88)	Date of publication A3:
	11.02.1999

(43)	Date of publication:
	26.01.2000 Bulletin 2000/04

(21)	Application number: 98914750.9

(22)	Date of filing: 07.04.1998

(51)	International Patent Classification (IPC)⁷: A61K 39/395

(86)	International application number:
	PCT/CA9800/325

(87)	International publication number:
	WO 9844/948 (15.10.1998 Gazette 1998/41)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

07.04.1997 US 41921 P

(71)	Applicant: Cangene Corporation
	Winnipeg, Manitoba R3T 2N2 (CA)

(72)	Inventors:
	PRICE, Hugh, W. Winnipeg, Manitoba R2M 0T8 (CA) WOLOSKI, B., Michael, R. Winnipeg, Manitoba R3T 2N2 (CA)

(74)	Representative: Harrison Goddard Foote
	Belmont House,20 Wood Lane Leeds LS6 2AE Leeds LS6 2AE (GB)

(54)	INTRAVENOUS IMMUNE GLOBULIN FORMULATION CONTAINING A NON-IONIC SURFACE ACTIVE AGENT WITH IMPROVED PHARMACOKINETIC PROPERTIES